Free tool
Diagnostics stocks
We cover 2 companies grouped under the Diagnostics theme. The median market value in the group is $14.76B. Across the group, the median move over the past trading day is +0.30%. Price change over the past year runs from +45.6% to +100.9% across the middle 80 percent of the group, with a median of +73.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% | Oct 20, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% | Oct 8, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.